ACSL5 and hepatocellular carcinoma: Under normoxic and hypoxic conditions, METTL3 and WTAP regulates ferro- ptosis through the PPARGC1A/BAM-BI/ACSL5 axis, promoting HCC progression and lenvatinib resistance